Cardiovascular autonomic neuropathy, autonomic symptoms and diabetic complications in 674 type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 82, Issue 2, 2008, Pages 282-290

  Chen, Hung Ta ^a   Lin, Hong Da ^b,c   Won, Justin G S ^b,c   Lee, Chen Hsen ^b,c   Wu, Shiao Chi ^c   Lin, Jiun Dian ^d   Juan, Li Ying ^e   Ho, Low Tone ^b,c   Tang, Kam Tsun ^b,c  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^e KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

Author keywords

Autonomic symptoms; Cardiovascular autonomic neuropathy; Cardiovascular reflex test; Diabetic nephropathy; Diabetic retinopathy

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; AUTONOMIC NEUROPATHY; CARDIOVASCULAR AUTONOMIC NEUROPATHY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; HUMAN; IMPOTENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; QT INTERVAL; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE;

AUTONOMIC NERVOUS SYSTEM; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; RISK FACTORS;

EID: 54549113047     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.08.012     Document Type: Article

References (43)

1. Wheeler S.G., Ahroni J.H., and Boyko E.J. Prospective study of autonomic neuropathy as a predictor of mortality in patients with diabetes. Diabetes Res. Clin. Pract. 58 (2002) 131-138
2. Chen H.S., Hwu C.M., Kuo B.I., Chiang S.C., Kwok C.F., Lee S.H., et al. Abnormal cardiovascular reflex tests are predictors of mortality in Type 2 diabetes mellitus. Diabet. Med. 18 (2001) 268-273
3. Gerritsen J., Dekker J.M., TenVoorde B.J., Kostense P.J., Heine R.J., Bouter L.M., et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 24 (2001) 1793-1798
4. Greene D.A., Lattimer S.A., and Sima A.A. Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?. Diabetes 37 (1988) 688-693
5. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care 15 (1992) 1835-1843
6. Apfel S.C., Arezzo J.C., Brownlee M., Federoff H., and Kessler J.A. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res. 634 (1994) 7-12
7. Low P.A., Nickander K.K., and Tritschler H.J. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 46 Suppl 2 (1997) S38-S42
8. Vinik A.I., Maser R.E., Mitchell B.D., and Freeman R. Diabetic autonomic neuropathy. Diabetes Care 26 (2003) 1553-1579
9. Gaede P., Vedel P., Larsen N., Jensen G.V., Parving H.H., and Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348 (2003) 383-393
10. Ewing D.J., Martyn C.N., Young R.J., and Clarke B.F. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8 (1985) 491-498
11. Ho L.T., Tang K.T., Wang L.M., Chang T.C., Jap T.S., and Kwok C.F. Reflex heart rate response in normal and diabetic subjects: relationship to age and skin microvascular reflexes. In: Ward J., and Goto Y. (Eds). Diabetic neuropathy (1990), John Wiley & Sons, England 379-393
12. Tang K.T., Ho L.T., Wang L.M., Lam H.C., Wang J.T., and Ching K.N. Reflex heart rate response in normal Chinese adults: its relationship to age. J. Formosan Med. Assoc. 87 (1987) 677-685
13. Ho L.T., Chou T.Y., Chen R.L., Deng P.R., Lin W.H., Jap T.S., et al. The diagnostic criteria of diabetic autonomic neuropathy. Proc. Natl. Sci. Counc. ROC(A) 6 (1982) 286-291
14. Bazett H.C. An analysis of the time-relations of electrocardiograms. Heart 7 (1920) 353-370
15. Friedewald W.T., LevyI R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
16. Boulton A.J., Vinik A.I., Arezzo J.C., Bril V., Feldman E.L., Freeman R., et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28 (2005) 956-962
17. American Diabetes Association, and American Association of Neurology. Consensus statement: report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes Care 11 (1988) 592-597
18. Neil H.A., Thompson A.V., Thorogood M., Fowler G.H., and Mann J.I. Diabetes in the elderly: the Oxford Community Diabetes Study. Diabet. Med. 6 (1989) 608-613
19. Toyry J.P., Niskanen L.K., Mantysaari M.J., Lansimies E.A., and Uusitupa M.I. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten-year follow-up from the diagnosis. Diabetes 45 (1996) 308-315
20. Low P.A., Benrud-Larson L.M., Sletten D.M., Opfer-Gehrking T.L., Weigand S.D., O'Brien P.C., et al. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care 27 (2004) 2942-2947
21. Ziegler D., Laux G., Dannehl K., Spuler M., Muhlen H., Mayer P., et al. Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet. Med. 9 (1992) 166-175
22. Veglio M., Carpano-Maglioli P., Tonda L., Quadri R., Giannella R., Rosa C., et al. Autonomic neuropathy in non-insulin-dependent diabetic patients: correlation with age, sex, duration and metabolic control of diabetes. Diabete. Metab. 16 (1990) 200-206
23. Kuroda N., Taniguchi H., Baba S., and Yamamoto M. Relationship between age and autonomic neuropathy in diabetes mellitus. Diabetes Res. Clin. Pract. 9 (1990) 49-53
24. Spallone V., Maiello M.R., Cicconetti E., and Menzinger G. Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes. Diabetes Res. Clin. Pract. 34 (1997) 169-179
25. Valensi P., Paries J., and Attali J.R. French Group for Research and Study of Diabetic Neuropathy. Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications-the French multicenter study. Metabolism 52 (2003) 815-820
26. Mustonen J., Uusitupa M., Mäntysaari M., Länsimies E., Pyörälä K., and Laakso M. Changes in autonomic nervous function during the 4-year follow-up in middle-aged diabetic and nondiabetic subjects initially free of coronary heart disease. J. Intern. Med. 241 (1997) 227-235
27. The Diabetes Control, Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
28. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
29. Hirsch J.A., and Bishop B. Respiratory sinus arrhythmia in humans: how breathing pattern modulates heart rate. Am. J. Physiol. 241 (1981) H620-H629
30. Straub R.H., Thum M., Hollerbach C., Palitzsch K.D., and Scholmerich J. Impact of obesity on neuropathic late complications in NIDDM. Diabetes Care 17 (1994) 1290-1294
31. Tentolouris N., Grapsas E., Stambulis E., Papageorgiou K., and Katsilambros N. Impact of body mass on autonomic function in persons with type 2 diabetes. Diabetes Res. Clin. Pract. 46 (1999) 29-33
32. Maser R.E., Pfeifer M.A., Dorman J.S., Kuller L.H., Becker D.J., and Orchard T.J. Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III. Arch. Intern. Med. 150 (1990) 1218-1222
33. Kempler P., Tesfaye S., Chaturvedi N., Stevens L.K., Webb D.J., Eaton S., and EURODIAB IDDM Complications Study Group. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabet. Med. 19 (2002) 900-909
34. Whitsel E.A., Boyko E.J., and Siscovick D.S. Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a meta-analysis. Diabetes Care 23 (2000) 241-247
35. Okin P.M., Devereux R.B., Lee E.T., Galloway J.M., and Howard B.V. Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the strong heart study. Diabetes 53 (2004) 434-440
36. Orchard T.J., LLoyd C.E., Maser R.E., and Kuller L.H. Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Res. Clin. Pract. 34 Suppl (1996) S165-S171
37. Viswanathan V., Prasad D., Chamukuttan S., and Ramachandran A. High prevalence and early onset of cardiac autonomic neuropathy among South Indian type 2 diabetic patients with nephropathy. Diabetes Res. Clin. Pract. 48 (2000) 211-216
38. Smulders Y.M., Jager A., Gerritsen J., Dekker J.M., Nijpels G., Heine R.J., et al. Cardiovascular autonomic function is associated with (micro-)albuminuria in elderly Caucasian sujects with impaired glucose tolerance or type 2 diabetes: the Hoorn Study. Diabetes Care 23 (2000) 1369-1374
39. Moran A., Palmas W., Field L., Bhattarai J., Schwartz J.E., Weinstock R.S., et al. Cardiovascular autonomic neuropathy is associated with microalbuminuria in older patients with type 2 diabetes. Diabetes Care 27 (2004) 972-977
40. Kastenbauer T., Irsigler P., Sauseng S., Grimm A., and Prager R. The prevalence of symptoms of sensorimotor and autonomic neuropathy in Type 1 and Type 2 diabetic subjects. J. Diabetes Complications 18 (2004) 27-31
41. Siu S.C., Lo S.K., Wong K.W., Ip K.M., and Wong Y.S. Prevalence of and risk factors for erectile dysfunction in Hong Kong diabetic patients. Diabet. Med. 18 (2001) 732-738
42. Kempler P., Tesfaye S., Chaturvedi N., Stevens L.K., Webb D.J., Eaton S., et al. Blood pressure response to standing in the diagnosis of autonomic neuropathy: the EURODIAB IDDM Complications Study. Arch. Physiol. Biochem. 109 (2001) 215-222
43. Maser R.E., and Lenhard M.J. Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J. Clin. Endocrinol. Metab. 90 (2005) 5896-5903